Zobrazeno 1 - 10
of 1 830
pro vyhledávání: '"Oxipurinol"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Adis International Limited
Publikováno v:
Drugs in R&D. 2004, Vol. 5 Issue 3, p171-175. 5p.
Autor:
Okamoto, Ken1 (AUTHOR), Eger, BryanT.2 (AUTHOR), Nishino, Tomoko1 (AUTHOR), Pai, EmilF.2 (AUTHOR), Nishino, Takeshi1 (AUTHOR) nishino@nms.ac.jp
Publikováno v:
Nucleosides, Nucleotides & Nucleic Acids. Jun/Jul2008, Vol. 27 Issue 6/7, p888-893. 6p. 1 Diagram, 1 Chart.
Xanthine oxidoreductase (XOR) is a molybdopterin-containing enzyme found in many living organisms. Its function is to convert hypoxanthine to xanthine and subsequently to urate, which are the final steps in purine elimination in humans. Elevated uric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67fd8b9153fc208ded2b4a1ca0112a73
https://doi.org/10.26434/chemrxiv-2023-bbq0j
https://doi.org/10.26434/chemrxiv-2023-bbq0j
Publikováno v:
Vom Wasser. 119:42-45
Autor:
Reinders, Mattheus K., Nijdam, Lars C., van Roon, Eric N., Movig, Kris L.L., Jansen, Tim L.Th.A., van de Laar, Mart A.F.J., Brouwers, Jacobus R.B.J.
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 2007 45(2):312-317
Autor:
Guerra, P., Frias, J., Ruiz, B., Soto, A., Carcas, A., Govantes, C., Montuenga, C., Fernandez, A.
Publikováno v:
Journal of Clinical Pharmacy & Therapeutics. Apr2001, Vol. 26 Issue 2, p133. 7p.
Autor:
Eric N. van Roon, Lars C. Nijdam, M.K. Reinders, Mart A F J van de Laar, T.L.Th.A. Jansen, Jacobus R. B. J. Brouwers, Kris L. L. Movig
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis, 45(2), 312-317. ELSEVIER SCIENCE BV
Journal of pharmaceutical and biomedical analysis, 45(2), 312-317. Elsevier
Journal of pharmaceutical and biomedical analysis, 45(2), 312-317. Elsevier
Objectives: Allopurinol is a uric acid lowering drug used in the treatment of gout and the prevention of tumor lysis syndrome. Allopurinol and its active metabolite oxipurinol inhibit xanthine oxidase, which forms uric acid from xanthine and hypoxant
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 27:888-893
Inhibitors of xanthine oxidoreductase block conversion of xanthine to uric acid and are therefore potentially useful for treatment of hyperuricemia or gout. We determined the crystal structure of reduced bovine milk xanthine oxidoreductase complexed
Publikováno v:
Pharmaceutisch Weekblad. 147(11):41-44